Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04110535 · ClinicalTrials.gov registry record · Phase 1
Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users
A Phase 1 study, sponsored by Paion UK.
- Completed
- Registry status
- Phase 1
- Development phase
- 83
- Enrollment target
NCT04110535 is a Phase 1 study that has completed, run by Paion UK. The registered enrollment target is 83 participants.
The verdict
NCT04110535, a Phase 1 study, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 83 participants
- Enrollment target
Study Summary
A double-blind, randomized crossover study to assess the subjective abuse potential of intravenous remimazolam compared to midazolam and placebo in recreational CNS depressant users
Interventions
- OTHER Saline
- DRUG Midazolam
- DRUG Remimazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2015-06-23 |
| Est. Completion | 2015-10-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04110535
The ClinicalTrials.gov registry entry for NCT04110535 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paion UK, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline is the first listed.
NCT04110535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04110535 about?
NCT04110535 is a clinical study titled "Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users". A double-blind, randomized crossover study to assess the subjective abuse potential of intravenous remimazolam compared to midazolam and placebo in recreational CNS depressant users
What is the current status of trial NCT04110535?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 83 participants. The study started on 2015-06-23. Estimated completion is 2015-10-06.
What interventions are being tested in trial NCT04110535?
The interventions under investigation include: Saline (OTHER), Midazolam (DRUG), Remimazolam (DRUG).
Who is sponsoring clinical trial NCT04110535?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.